D'Andrea Vito, Barone Giovanni, Pezza Lucilla, Prontera Giorgia, Vento Giovanni, Pittiruti Mauro
Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
Neonatal Intensive Care Unit, Azienda Sanitaria Romagna, Infermi Hospital Rimini, Rimini, Italy.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):6747-6750. doi: 10.1080/14767058.2021.1922377. Epub 2021 May 9.
Accidental dislodgement of central venous catheters is a frequent complication in NICU and it often requires catheter replacement. Subcutaneously anchored sutureless devices (SAS) have been recently introduced in clinical practice for securement of different types of central catheters, but they have never been used in neonates. We evaluated safety and efficacy of SAS in neonates.
All neonates who required central venous catheters inserted ultrasound-guided cannulation during 12 months of clinical practice in our NICU. We adopted SAS for securement of all central venous catheters inserted in neonates ultrasound guided cannulation either of the brachio-cephalic vein (centrally inserted central catheters: CICC) or the femoral vein (femorally inserted central catheters: FICC). Results: seventy-two central catheters were inserted in 70 preterm and term neonates (3-4 Fr power injectable polyurethane catheters; 62 CICC + 10 FICC) and they were all secured with SAS. Mean postmenstrual age at the time of insertion was 31 weeks and mean weight was 1400 g. SAS was easy to place in all cases. The median duration of the line was 6 weeks. No accidental dislodgement of CICC or FICC was recorded. All SAS but one were left in place until elective removal of the catheter. In all patients, SAS removal was easy and uneventful, and it did not require any sedation or local anesthesia. Conclusions: SAS was effective in preventing accidental catheter dislodgement in 100% of cases. Complications during insertion, maintenance and removal were negligible.
中心静脉导管意外移位是新生儿重症监护病房(NICU)常见的并发症,常需更换导管。皮下锚定无缝合装置(SAS)最近已引入临床实践,用于固定不同类型的中心导管,但从未在新生儿中使用过。我们评估了SAS在新生儿中的安全性和有效性。
在我们NICU 12个月的临床实践中,所有需要中心静脉导管的新生儿均采用超声引导下插管。我们采用SAS固定所有在超声引导下经头臂静脉(中心插入中心导管:CICC)或股静脉(股静脉插入中心导管:FICC)插管的新生儿中心静脉导管。结果:70例早产儿和足月儿(3-4Fr可用于功率注射的聚氨酯导管;62例CICC+10例FICC)共插入72根中心导管,均用SAS固定。插入时的平均胎龄为31周,平均体重为1400g。在所有病例中,SAS都很容易放置。导管的中位留置时间为6周。未记录到CICC或FICC的意外移位。除一根外,所有SAS均留置至择期拔除导管。在所有患者中,SAS拔除容易且顺利,无需任何镇静或局部麻醉。结论:SAS在100%的病例中有效防止了导管意外移位。插入、维护和拔除过程中的并发症可忽略不计。